Behind the Breakthroughs

Behind the Breakthroughs

By Inside Precision MedicineScienceMedicineHealth & FitnessLife Sciences
Download on the App Store

Behind the Breakthroughs episodes

  • Kian Sadeghi: Is Personalized Genomics Undergoing a Direct-to-Consumer Renaissance?

    At just 25, UPenn dropout Kian Sadeghi is betting big on personalized genomics. As founder of Nucleus Genomics, he’s offering affordable whole-genome sequencing direct to consumers and rethinking how patients, clinicians, and insurers engage with genetic data. On Behind the Breakthroughs, Sadeghi unpacks the fall of 23andMe, the rise of patient agency, and why he thinks genomics needs its own Bill Gates.


    Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.


    Produced by Bill Levine

    Hosted by Jonathan D. Grinstein

    Audio mixed and mastered by Jason Mack

    Music provided by Artem Hramushkin

    Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what it will take for them to work. Host Jonathan D. Grinstein, PhD, a scientist-turned-journalist, speaks with the researchers, physicians, and entrepreneurs building the next generation of genetic medicines, diagnostics, AI, precision therapeutics, and biotechnology.

    Hosted on Acast. See acast.com/privacy for more information.

    45 min
  • Carlos D. Bustamante: Latin American Diversity’s Genetic Potential

    Imagine a future where your ancestry not only tells a story about your past but also holds the key to your health. That's the vision drives Carlos D. Bustamante, PhD, population geneticist and founder of Galatea Bio, as he embarks on an ambitious mission: building a biobank of 10 million genomes to transform drug development and healthcare across Latin America. With thousands of founder populations scattered across the region—from the valleys of Medellín to the islands of the Caribbean—Latin America is a goldmine of genetic diversity. Yet, until now, it has been largely overlooked in genomic research. In this Behind the Breakthroughs episode, Bustamante explains why mapping this diversity can uncover genetic insights that will lead to better treatments for diseases that disproportionately affect these communities.


    Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.


    Produced by Bill Levine

    Hosted by Jonathan D. Grinstein

    Music provided by Artem Hramushkin

    Audio mixed and mastered by Jason Mack

    Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what it will take for them to work. Host Jonathan D. Grinstein, PhD, a scientist-turned-journalist, speaks with the researchers, physicians, and entrepreneurs building the next generation of genetic medicines, diagnostics, AI, precision therapeutics, and biotechnology.

    Hosted on Acast. See acast.com/privacy for more information.

    51 min
  • Josh Denny: The Future of Precision Public Health

    Josh Denny, MD, turned a family tragedy with cystic fibrosis into a lifelong mission to transform medicine. Now CEO of the NIH’s All of Us Research Program, he’s leading one of the largest precision medicine efforts in history—850,000 participants strong with 400,000 genomic profiles and counting. On Behind the Breakthroughs, Denny shares how this unprecedented dataset could rewrite the future of healthcare, from rare disease to everyday care.


    Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.


    Produced by Bill Levine

    Hosted by Jonathan D. Grinstein

    Music provided by Artem Hramushkin

    Audio mixed and mastered by Jason Mack

    Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what it will take for them to work. Host Jonathan D. Grinstein, PhD, a scientist-turned-journalist, speaks with the researchers, physicians, and entrepreneurs building the next generation of genetic medicines, diagnostics, AI, precision therapeutics, and biotechnology.

    Hosted on Acast. See acast.com/privacy for more information.

    40 min
  • Uli Stilz: Conquering Complex Diseases Affecting Billions with Precision Medicine

    The sage-like Uli Stilz, PhD, Vice President of Novo Nordisk, provides insight into the inner workings of Novo Nordisk’s Bio Innovation Hub, which he founded in Boston, to tackle complex, multifactorial diseases that impact billions of people, such as diabetes and cardiometabolic diseases.


    Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.


    Produced by Bill Levine

    Hosted by Jonathan D. Grinstein

    Music provided by Artem Hramushkin

    Audio mixed and mastered by Jason Mack

    Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what it will take for them to work. Host Jonathan D. Grinstein, PhD, a scientist-turned-journalist, speaks with the researchers, physicians, and entrepreneurs building the next generation of genetic medicines, diagnostics, AI, precision therapeutics, and biotechnology.

    Hosted on Acast. See acast.com/privacy for more information.

    35 min
  • Tomasz (Tom) Beer: Detecting Cancer Before Symptoms? MCED Leads the Way

    Despite advances in screening, only one in six U.S. cancers is detected early. Tomasz (Tom) Beer, MD, left most of his clinical practice to join Exact Sciences and push the frontier with blood-based multicancer early detection (MCED) tests. On Behind the Breakthroughs, Beer explains how these tests could transform cancer screening and catch disease before it’s too late.


    Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.


    Produced by Bill Levine

    Hosted by Jonathan D. Grinstein

    Music provided by Artem Hramushkin

    Audio mixed and mastered by Jason Mack

    Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what it will take for them to work. Host Jonathan D. Grinstein, PhD, a scientist-turned-journalist, speaks with the researchers, physicians, and entrepreneurs building the next generation of genetic medicines, diagnostics, AI, precision therapeutics, and biotechnology.

    Hosted on Acast. See acast.com/privacy for more information.

    27 min
  • Katy Rezvani: Allogeneic NK Cells Are Coming to Beat Cancer at a Clinic Near You

    Katy Rezvani, MD, PhD, turned her fascination with immunology into a career engineering allogeneic immune cell therapies. On Behind the Breakthroughs, Rezvani explains why NK cells—unlike T cells—hold promise for safer, more accessible cancer treatments, and how her work at MD Anderson is shaping the future of cell therapy.


    Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.


    Produced by Bill Levine

    Hosted by Jonathan D. Grinstein, PhD

    Music provided by Artem Hramushkin

    Audio mixed and mastered by Jason Mack

    Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what it will take for them to work. Host Jonathan D. Grinstein, PhD, a scientist-turned-journalist, speaks with the researchers, physicians, and entrepreneurs building the next generation of genetic medicines, diagnostics, AI, precision therapeutics, and biotechnology.

    Hosted on Acast. See acast.com/privacy for more information.

    40 min
  • Toby Ferguson: From Bloodstream to Brain: Accessing the Neurogenetic Medicine Revolution

    "Are we close to curing diseases like ALS and Alzheimer's?" In recent years, several academic and industry endeavors have given reason to be hopeful. Toby Ferguson, MD, PhD, is the Chief Medical Officer at Voyager Therapeutics, which develops genetic medicines and delivery tools to cross the blood-brain barrier (BBB). In this episode, Ferguson explains the current state of therapeutics for neurological and neurodegenerative diseases, challenges in delivering genetic medicines and other therapeutics to the nervous system, and Voyager's approach to overcoming the BBB.


    Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.


    Produced by Bill Levine

    Hosted by Jonathan D. Grinstein

    Music provided by Artem Hramushkin

    Audio mixed and mastered by Jason Mack

    Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what it will take for them to work. Host Jonathan D. Grinstein, PhD, a scientist-turned-journalist, speaks with the researchers, physicians, and entrepreneurs building the next generation of genetic medicines, diagnostics, AI, precision therapeutics, and biotechnology.

    Hosted on Acast. See acast.com/privacy for more information.

    30 min
  • Tomi Pastinen: Treating All the Not-So-Rare “Rare Disease” Patients at Major Care Centers

    Tomi Pastinen, MD, PhD, is transforming pediatric medicine through genomics. As Director at Children’s Mercy Kansas City, he’s pioneered pharmacogenetic testing and 5-nucleotide genomic sequencing, bringing precision medicine to children. On Behind the Breakthroughs, Pastinen discusses the promise—and challenges—of turning genetic diagnoses into real treatments, from rare inherited diseases to complex conditions like autism.


    Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.


    Produced by Bill Levine

    Hosted by Jonathan D. Grinstein

    Music provided by Artem Hramushkin

    Audio mixed and mastered by Jason Mack

    Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what it will take for them to work. Host Jonathan D. Grinstein, PhD, a scientist-turned-journalist, speaks with the researchers, physicians, and entrepreneurs building the next generation of genetic medicines, diagnostics, AI, precision therapeutics, and biotechnology.

    Hosted on Acast. See acast.com/privacy for more information.

    31 min
  • Tom Whitehead: Not All Precision Medicine Heroes Wear Lab Coats

    Tom Whitehead, father of Emily Whitehead—the first pediatric CAR T patient—turned a harrowing journey into a mission to help families navigating life-threatening illness. On Behind the Breakthroughs, he shares the emotional story of Emily’s treatment and the challenges patients face when cutting-edge research intersects with real-world care.


    This is the 2024 finale for Behind the Breakthroughs, and we will release our next episode on January 8, 2025.


    Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.


    Produced by Bill Levine

    Hosted by Jonathan D. Grinstein

    Music provided by Artem Hramushkin

    Audio mixed and mastered by Jason Mack

    Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what it will take for them to work. Host Jonathan D. Grinstein, PhD, a scientist-turned-journalist, speaks with the researchers, physicians, and entrepreneurs building the next generation of genetic medicines, diagnostics, AI, precision therapeutics, and biotechnology.

    Hosted on Acast. See acast.com/privacy for more information.

    32 min
  • Harry Clifford: Carrying Medicine Into the Post-Moore’s Law Era

    Harry Clifford, PhD, Digital Biology Lead at NVIDIA, discusses how the computer manufacturing and AI computing leader is building a technology platform to address data bottlenecks in drug development and healthcare to advance precision medicine.


    Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.


    Produced by Bill Levine

    Hosted by Jonathan D. Grinstein

    Music provided by Artem Hramushkin

    Audio mixed and mastered by Jason Mack

    Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what it will take for them to work. Host Jonathan D. Grinstein, PhD, a scientist-turned-journalist, speaks with the researchers, physicians, and entrepreneurs building the next generation of genetic medicines, diagnostics, AI, precision therapeutics, and biotechnology.

    Hosted on Acast. See acast.com/privacy for more information.

    27 min

About Behind the Breakthroughs

From the publisher's feed

Medicine is full of breakthroughs. Most don't become medicine. Behind the Breakthroughs explores scientific ideas that could change how we diagnose and treat disease—and what…

More shows like Behind the Breakthroughs

Nature Podcast by Springer Nature Limited

Nature Podcast

767 Listeners

The Daily by The New York Times

The Daily

112,285 Listeners

Call Me Back - with Dan Senor by Ark Media

Call Me Back - with Dan Senor

3,228 Listeners

Unexplainable by Vox

Unexplainable

2,304 Listeners

Touching Base by Genetic Engineering & Biotechnology News (GEN)

Touching Base

4 Listeners